Physician

Bala Kanagaraju, MD

According to 2025 Medicare claims, Bala Kanagaraju, MD (NPI: 1851315469) practices general practice in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is BALA KANAGARAJU, M.D.S.C (NPI: 1295050821) and primary practice location at 60620-4335.

Kanagaraju's data goes back to 2015 and runs through 2024. Part D data shows 439 prescription claims across 26 beneficiaries totaling $13,342 in drug costs, led by Atorvastatin Calcium (Atorvastatin Calcium). DME data shows 72 claims. Open Payments data shows 1 records totaling $32. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $6,173 and ending at $13,342. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	239	$6,173
2016	11	288	$13,274
2017	15	283	$11,137
2018	16	314	$17,766
2019	19	449	$30,503
2020	27	567	$36,764
2021	31	570	$17,806
2022	29	507	$16,987
2023	40	676	$28,935
2024	26	439	$13,342

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	72	72	$57,157
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Atorvastatin Calcium	Atorvastatin Calcium	103	3,930	$317
Albuterol Sulfate Hfa	Albuterol Sulfate	14	365	$238
Amlodipine Besylate	Amlodipine Besylate	76	2,700	$221
Nifedipine Er	Nifedipine	14	420	$131
Allopurinol	Allopurinol	24	720	$44

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$32	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bala Kanagaraju, MD?

Tedicare shows public-source Medicare data for Bala Kanagaraju, MD (NPI 1851315469), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bala Kanagaraju, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bala Kanagaraju, MD?

Bala Kanagaraju, MD is linked to BALA KANAGARAJU, M.D.S.C (billing NPI 1295050821) in the available physician profile data.

Does Bala Kanagaraju, MD have Open Payments data?

Bala Kanagaraju, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.